Exchange: NASDAQ·Updated 12:48 PM EDT
News
all
press releases
Pulmonx Corporation (LUNG) Reports Q2 Loss, Beats Revenue Estimates
Pulmonx (LUNG) delivered earnings and revenue surprises of +14.29% and +2.34%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
More News
What Does the HeartFlow CEO's Sale of Over 20,000 Company Shares Mean for Investors?
Key PointsCEO John Farquhar disposed of 22,562 shares at a transaction value of ~$626,100 on July 10, 2026...
Nasdaq News: Markets
Heartflow vs. Omeros: Which Healthcare Innovator Stock Is a Better Buy in 2026?
Key PointsHeartflow uses artificial intelligence to transform coronary imaging into actionable diagnostic data for heart disease...
Nasdaq News: Markets
Heartflow vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Heartflow vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026...
Yahoo! Finance: News
HeartFlow vs. NovoCure: Which Emerging Healthcare Stock Is a Better Buy in 2026?
Key PointsHeartFlow uses AI-driven software to transform cardiac diagnostics through non-invasive heart scans...
Nasdaq News: Markets
16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart Gap
16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart Gap 16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart Gap PR Newswire TORONTO, ON, June 16, 2026 Issued on behalf of Ventripoint Diagnostics Ltd.As the number of...
PR Newswire
Is HeartFlow Stock a Buy After an Institutional Investor Initiated a Position Worth $2.7 Million?
Key PointsIntrepid Family Office LLC bought 110,000 HeartFlow shares...
Nasdaq News: Markets
Stanford Trustees Exited HeartFlow Stock for $8.5 Million. Here's What That Means for Investors.
Key PointsStanford Trustees sold 312,234 shares of HeartFlow for an estimated trade value of $8.48 million based on quarterly average pricing...
Nasdaq News: Markets
Heartflow (NASDAQ:HTFL) Major Shareholder Bain Capital Life Sciences Inv Sells 948,757 Shares
Heartflow, Inc. (NASDAQ:HTFL - Get Free Report) major shareholder Bain Capital Life Sciences Inv sold 948,757 shares of the business's stock in a transaction on Thursday, April 30th. The shares were...
MarketBeat
Insider Selling: Heartflow (NASDAQ:HTFL) Major Shareholder Sells 797,133 Shares of Stock
Heartflow, Inc. (NASDAQ:HTFL - Get Free Report) major shareholder Bain Capital Life Sciences Inv sold 797,133 shares of the business's stock in a transaction that occurred on Wednesday, April 29th...
MarketBeat

Advertisement|Remove ads.